LUTS-Lower Urinary Tract Symptoms

Papers
(The TQCC of LUTS-Lower Urinary Tract Symptoms is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information38
25
Anatomic outcomes of sacrohysteropexy without posterior mesh placement in patients with asymptomatic grade 1 and 2 rectoceles: Is a rectouterine mesh really necessary?24
Effects of transobturator tape procedure on female sexual function at 2‐year follow‐up: A prospective cohort study with matched control group22
Predictive urodynamic factors for de novo stress urinary incontinence after laparoscopic sacrocolpopexy for pelvic organ prolapse15
The Value of Urethral Pressure Profile Using Air‐Charged Catheters in the Diagnosis of Female Bladder Neck Obstruction15
Efficacy of cognitive behavioral therapy using self‐check sheet for patients with nocturia in real‐world clinical practice12
Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia11
9
Cystectomy for patients with Hunner‐type interstitial cystitis at a tertiary referral center in Japan9
Intravesical injections of autologousplatelet‐richplasma for the treatment of refractory interstitial cystitis8
Editorial8
Collateral damage of wandering ProTacks8
Corrigenda7
7
Quality and content analysis of female urethroplasty videos on YouTube7
6
Issue Information6
Effectiveness of game‐based core exercise in children with non‐neuropathic bladder dysfunction and comparison to biofeedback therapy6
Quality of Life After Augmentation Enterocystoplasty in Children6
The expression and distribution of TACAN in human and rat bladders6
Issue Information6
Issue Information6
The efficacy and safety of desmopressin acetate applied for nocturia in benign prostatic hyperplasia patients: A systematic review and meta‐analysis6
Issue Information6
Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real‐world clinical practice in Japan, SCCOP study 19‐016
Issue Information6
Lower urinary tract symptoms in patients with small prostates: Smooth muscle proliferation and calcification might be causative factors6
Transient Receptor Potential Melastatin 8 Contributes to Cystitis‐Induced Neuronal Sprouting and Pain Hypersensitivity Through AKT/mTOR Signaling Pathway in Interstitial Cystitis6
6
Association between voiding lower urinary tract symptoms and findings on dynamic magnetic resonance imaging with regard to pelvic organs and their supportive structures5
Factors affecting urinary frequency after low‐dose‐rate brachytherapy for prostate cancer5
Influence of background characteristics in responders of regenerative therapy by periurethral injection of adipose‐derived regenerative cells for male stress urinary incontinence5
Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: A urologist's perspective5
Digit Length Ratio as an Indicator of Fetal Androgen Levels: Relationship to Prostate Volume‐Related Men Lower Urinary Tract Symptoms5
Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg4
Does urinary urgency drive urinary frequency in overactive bladder?4
Effect of intravesical tarantula cubensis extract (Theranekron) on inflammation in an interstitial cystitis rat model4
Freeflow: The novel portable uroflowmeter can help to realize practical urinary conditions at home4
Memorial address for Emeritus Professor Osamu Yamaguchi—A man of learning4
Issue Information4
3
The efficacy of antibiotic and alpha‐blocker combination therapy versus antibiotic monotherapy in chronic prostatitis/chronic pelvic pain syndrome: A systematic review3
Efficacy and safety of the Rezum system for the treatment of catheter‐dependent urinary retention: Three‐year real‐world outcomes in a multimorbid, multiethnic population3
Issue Information3
Influence of the median lobe on the results at 4 years of the prostate vaporization by GreenLight laser3
Issue Information3
Prevalence of symptoms of pelvic floor dysfunction and related factors among Japanese female healthcare workers3
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms—A randomized controlled trial3
0.055731058120728